藥明生物
WuXi Biologics (Cayman) IncUSUSDWuXi Biologics (Cayman) Inc (US:WXIBF) — Biotechnology. Брой борси, на които се търгуват акциите на компанията: 2. На тази страница — цена и график, дивиденти, най-големи акционери и история на броя на акциите.
За компанията
- Уебсайт
- wuxibiologics.com
- Сектор
- Healthcare · Biotechnology
- Централа
- Wuxi, China
- Изпълнителен директор
- Zhisheng Chen
- Служители
- 14 705
- Акции в обращение
- Свободно търгуеми акции
- 3.71 млрд
- Пазарна капитализация
- 221.69 млрд HKD
- Инсайдери
- 10.12%
- Институционални инвеститори
- 36.36%
- Правна форма
- OSBR
- ISIN
- KYG970081173
- LEI
- 5493001TD2TH6VDTJU11
Описание
WuXi Biologics (Cayman) Inc., an investment holding company, provides end-to-end solutions and services for biologics discovery, development, and manufacturing for biologics industry in the People's Republic of China, North America, Europe, Singapore, Japan, South Korea, Australia, and Brazil. It operates through two segments: Biologics and XDC. The company provides a suite of solutions for biologic discovery, from concept to IND, that seamlessly transits to CMC and downstream process development through its contract research, development, and manufacturing organization platforms, including WuXiBody, SDArBodY, T cell engager, Tumor Associated Antigens (TAA) mAb Technology, Single B Cell Cloning Technology, WuXia, WuXiUP, WuXiUI, and WuXiHigh. It engages in the provision of consultation services in relation to the biopharmaceutical technology, international sales contracting services, testing and development of testing technologies, sales and marketing services, production and sales of medicals, and biologics clinical and manufacturing services; research and development in relation to biologics; international sales contracting service; vaccine contract development and manufacturing organization (CDMO) and related business; development, production, and distribution of biotechnological products; and engages in investment and material supplier activities. WuXi Biologics (Cayman) Inc. was incorporated in 2014 and is headquartered in Wuxi, China.
Новини тази седмица
Прессъобщения от уебсайта на компанията за инвеститори, актуализирани ежедневно. Линковете водят към уебсайта на компанията. Заглавията са на оригиналния език, както е на уебсайта на компанията.
Най-големи притежатели
| Притежател | Дял | Акции | Дата на доклада |
|---|---|---|---|
| VANGUARD STAR FUNDS-Vang… | 1.34% | 55.13 млн | 2026-07-31 |
| VANGUARD Intl Eqy. INDEX… | 1.27% | 52.41 млн | 2026-07-31 |
| Chen (Zhisheng) (Chief E… | ≈1.19% | 49.19 млн | 2026-09-11 |
| iShares, Inc.-iShares Co… | 0.97% | 40.12 млн | 2026-08-31 |
| VANGUARD WORLD FUND-Vang… | 0.92% | 37.93 млн | 2026-05-31 |
| American Century ETF Tru… | 0.27% | 11.01 млн | 2026-08-31 |
| J.P. Morgan Exch-Trd Fd.… | 0.26% | 10.87 млн | 2026-07-31 |
| VANGUARD Intl Eqy. INDEX… | 0.22% | 8.96 млн | 2026-07-31 |
| iShares, Inc.-iShares MS… | 0.22% | 8.91 млн | 2026-08-31 |
| Baird Funds Inc-Baird Ch… | 0.21% | 8.77 млн | 2026-07-31 |
| iShares Trust-iShares MS… | 0.21% | 8.76 млн | 2026-08-31 |
| Zhou (Weichang) (Chief T… | ≈0.14% | 5.6 млн | 2025-06-02 |
| Gu (Xuejun Sherry) (Chie… | ≈0.03% | 1.37 млн | 2026-08-24 |
| Boston Common Asset Mana… | 0.02% | 869 000 | 2024-03-31 |
| Li (Ge) (Chairman of the… | — | — | 2026-01-20 |
